PMI is a multiagency initiative, led by the U.S. Agency for International Development (USAID) and co-implemented with the U.S. Department of Health and Human Services’ Centers for Disease Control and Prevention (CDC). PMI has strong support from and collaborates closely with the White House and National Security Council, Department of Defense, National Institutes of Health, Peace Corps, and other U.S. government entities. PMI works hand in hand with national malaria programs and supports partner governments’ national malaria strategies. PMI also engages with the Global Fund to Fight AIDS, Tuberculosis, and Malaria (Global Fund); local research institutions and universities; nongovernmental organizations; faith and community groups; and the private sector to strengthen local leadership and wideranging investment in fighting malaria.

2 results

The President's Malaria Initiative 16th Annual Report to Congress

This past year was one of the most challenging in our recent history as the global community continued to respond to the COVID-19 pandemic. COVID-19 greatly impacted malaria control efforts by disrupting supply chains for antimalarial medicines, overburdening and infecting health workers, and making communities unable or fearful of seeking needed testing and treatment. In 2020, there were an estimated 14 million more malaria cases and 69,000 more deaths than in 2019.

The President’s Malaria Initiative 15th Annual Report to Congress

Pandemics are global but their impact is personal. When I first contracted malaria as an infant, my mother was worried sick. We lived in Liberia where, as is still the case in many African countries, if you don’t know someone who died from malaria you know someone who suffered from it.